# EDGAR Filing Document

**Accession Number:** 0002099039
**File Stem:** 0002131391-26-000002
**Filing Date:** 2026-5
**Character Count:** 11565
**Document Hash:** fbbf5ee4772ea702821b66349d712584
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002131391-26-000002.hdr.sgml**: 20260508

**ACCESSION NUMBER**: 0002131391-26-000002

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260508

**FILED AS OF DATE**: 20260508

**DATE AS OF CHANGE**: 20260508

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Sinha Harsh
- **CENTRAL INDEX KEY:** 0002131391

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43229
- **FILM NUMBER:** 26960181

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** C/O WISE GROUP PLC
- **STREET 2:** 1ST FLOOR WORSHIP SQ., 65 CLIFTON STREET
- **CITY:** LONDON
- **PROVINCE COUNTRY:** X0
- **ZIP:** EC2A 4JE
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Wise Group plc
- **CENTRAL INDEX KEY:** 0002099039
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** Y9
- **FISCAL YEAR END:** 0331

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 65 CLIFTON STREET
- **CITY:** LONDON
- **PROVINCE COUNTRY:** X0
- **ZIP:** EC2A 4JE
- **BUSINESS PHONE:** 44 20 3974 1321

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 65 CLIFTON STREET
- **CITY:** LONDON
- **PROVINCE COUNTRY:** X0
- **ZIP:** EC2A 4JE

## Ex-24

**POWER OF ATTORNEY**

(For Executing Forms 3, 4, and 5)

Know all by these presents, that the undersigned hereby constitutes and appoints each of Jane Fahey, Daniel Rados, David Fu and Nameeta Pai of Wise Group plc (the "***Company***"), signing individually, the undersigned's true and lawful attorneys-in-fact and agents to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the Securities and Exchange Commission (the "***SEC***") Forms 3, 4 and 5 (including any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "***Exchange Act***"), and the rules thereunder in the undersigned's capacity as an officer, director or beneficial owner of more than 10% of a registered class of securities of the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to execute such Forms 3, 4 or 5 (including amendments thereto) and timely file such forms with the SEC and any stock exchange or any similar authority; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) take any other action of any type whatsoever in connection with the foregoing that, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required of the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in the attorney-in-fact's discretion.

The undersigned hereby grants to each such attorneyinfact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorneyinfact, or such attorneyinfact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, and their substitutes, in serving in such capacity at the request of the undersigned, are not assuming (nor is the Company assuming) any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the Company and the foregoing attorneys-in fact or (c) as to any attorney-in-fact individually, until such attorney-in-fact is no longer employed by the Company.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date written below.

Date: <u>16 April 2026</u>

<u>/s/ Harsh Sinha</u>

Name: Harsh Sinha

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Sinha Harsh<br><sub>(Last) (First) (Middle)</sub><br>C/O WISE GROUP PLC<br>1ST FLOOR WORSHIP SQ., 65 CLIFTON STREET<br><sub>(Street)</sub><br>LONDON, UNITED KINGDOM EC2A 4JE<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Wise Group plc [ WSE ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-05-08 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Chief Technology Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Class A Ordinary Shares | 810875 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Employee Share Option (right to buy) | <sup>(1)</sup> | 2030-08-26 | Class A Ordinary Shares | 130000 | <sup>(2)</sup> | D |  |
| Employee Share Option (right to buy) | <sup>(1)</sup> | 2029-07-12 | Class A Ordinary Shares | 227500 | <sup>(3)</sup> | D |  |
| Employee Share Option (right to buy) | <sup>(1)</sup> | 2028-03-06 | Class A Ordinary Shares | 455000 | <sup>(4)</sup> | D |  |
| Restricted Share Units | <sup>(5)</sup> | <sup>(5)</sup> | Class A Ordinary Shares | 52620 | <sup>(6)</sup> | D |  |
| Restricted Share Units | <sup>(7)</sup> | <sup>(7)</sup> | Class A Ordinary Shares | 157859 | <sup>(6)</sup> | D |  |
| Restricted Share Units | <sup>(8)</sup> | <sup>(8)</sup> | Class A Ordinary Shares | 263097 | <sup>(6)</sup> | D |  |
| Restricted Share Units | <sup>(9)</sup> | <sup>(9)</sup> | Class A Ordinary Shares | 368332 | <sup>(6)</sup> | D |  |

---

### Footnotes:

(1) Fully vested and exercisable.

(2) The initial exercise price for the option award was 3.1969 GBP. In connection with the effectiveness of the Issuer's Scheme of Arrangement on May 8, 2026, the option award was assumed by the Issuer and the exercise price thereof was converted from British pound sterling to U.S. dollars using a mid-market exchange rate on May 8, 2026, which is not yet available as of the time of this initial statement of beneficial ownership of securities. The Reporting Person undertakes to provide in a subsequent statement of changes in beneficial ownership full information regarding the exercise price for the option award following the conversion described above.

(3) The initial exercise price for the option award was 1.911 GBP. In connection with the effectiveness of the Issuer's Scheme of Arrangement on May 8, 2026, the option award was assumed by the Issuer and the exercise price thereof was converted from British pound sterling to U.S. dollars using a mid-market exchange rate on May 8, 2026, which is not yet available as of the time of this initial statement of beneficial ownership of securities. The Reporting Person undertakes to provide in a subsequent statement of changes in beneficial ownership full information regarding the exercise price for the option award following the conversion described above.

(4) The initial exercise price for the option award was 0.5745 GBP. In connection with the effectiveness of the Issuer's Scheme of Arrangement on May 8, 2026, the option award was assumed by the Issuer and the exercise price thereof was converted from British pound sterling to U.S. dollars using a mid-market exchange rate on May 8, 2026, which is not yet available as of the time of this initial statement of beneficial ownership of securities. The Reporting Person undertakes to provide in a subsequent statement of changes in beneficial ownership full information regarding the exercise price for the option award following the conversion described above.

(5) The restricted share units ("RSUs") will vest in two equal installments on July 15, 2026 and October 15, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

(6) Each RSU represents a contingent right to receive one Issuer Class A Ordinary Share or cash.

(7) The RSUs will vest in six equal quarterly installments commencing on July 15, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

(8) The RSUs will vest in ten equal quarterly installments commencing on July 15, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

(9) The RSUs will vest in fourteen equal quarterly installments commencing on July 15, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

**Signature:** /s/ Nameeta Pai, Attorney-in-Fact  
**Date:** 2026-05-08

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**